Profile
Full Name
Ocular Therapeutix, Inc.Ticker Symbol
OCULExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 25, 2014Indexes
Not includedWebsite
http://www.ocutx.comEmployees
274Key Details
Price
$7.31(+1.95%)
Market cap
$1.16B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$63.72M(+9.03% YoY)
Annual EPS
-$1.22(-19.61% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Ocular Therapeutix doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 8, 25 William Blair
OutperformApr 8, 25 Needham
BuyMar 18, 25 RBC Capital
OutperformMar 11, 25 Needham
BuyMar 4, 25 HC Wainwright & Co.
BuyMar 4, 25 Citizens Capital Markets
Market OutperformDec 3, 24 HC Wainwright & Co.
BuyNov 15, 24 HC Wainwright & Co.
BuyOct 16, 24 Scotiabank
Sector OutperformOct 16, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Ocular Therapeutix?
- Does Ocular Therapeutix pay dividends?
- What sector is Ocular Therapeutix in?
- What industry is Ocular Therapeutix in?
- What country is Ocular Therapeutix based in?
- When did Ocular Therapeutix go public?
- Is Ocular Therapeutix in the S&P 500?
- Is Ocular Therapeutix in the NASDAQ 100?
- Is Ocular Therapeutix in the Dow Jones?
- When was Ocular Therapeutix's last earnings report?
- When does Ocular Therapeutix report earnings?
- Should I buy Ocular Therapeutix stock now?
What is the ticker symbol for Ocular Therapeutix?
The ticker symbol for Ocular Therapeutix is NASDAQ:OCUL
Does Ocular Therapeutix pay dividends?
No, Ocular Therapeutix does not pay dividends
What sector is Ocular Therapeutix in?
Ocular Therapeutix is in the Healthcare sector
What industry is Ocular Therapeutix in?
Ocular Therapeutix is in the Biotechnology industry
What country is Ocular Therapeutix based in?
Ocular Therapeutix is headquartered in United States
When did Ocular Therapeutix go public?
Ocular Therapeutix's initial public offering (IPO) was on July 25, 2014
Is Ocular Therapeutix in the S&P 500?
No, Ocular Therapeutix is not included in the S&P 500 index
Is Ocular Therapeutix in the NASDAQ 100?
No, Ocular Therapeutix is not included in the NASDAQ 100 index
Is Ocular Therapeutix in the Dow Jones?
No, Ocular Therapeutix is not included in the Dow Jones index
When was Ocular Therapeutix's last earnings report?
Ocular Therapeutix's most recent earnings report was on Mar 3, 2025
When does Ocular Therapeutix report earnings?
The next expected earnings date for Ocular Therapeutix is May 7, 2025
Should I buy Ocular Therapeutix stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions